Skip to content
Search

Latest Stories

GPhC makes case for Covid-19 vaccination in all pharmacies; RPS says policy reversal by government gives little hope to those already affected

Following the UK government’s decision to look at the possibility of changing rules on mandatory Covid vaccination for healthcare staff, the General Pharmaceutical Council (GPhC) said it would continue to “underline the case for taking up Covid-19 vaccination in all pharmacy settings.”

Duncan Rudkin, chief executive of the GPhC, said: “It is important that there is a consistent approach for health professionals across the UK, and so we will work closely with the other health professional regulators, governments, pharmacy professional bodies and employers as we take this forward.”


The Council strongly reminded all pharmacists and pharmacy technicians to take their Covid-19 vaccinations, unless medically exempted.

It also asked them to encourage other members of their teams to get vaccinated as well.

“Getting vaccinated protects the individual, their family, and colleagues, as well as patients and the public,” Rudkin said.

Likewise, chair of the Royal Pharmaceutical Society in England Thorrun Govind said: “We have always encouraged pharmacy teams to have any vaccine necessary to help protect themselves, but did not support making COVID-19 vaccinations mandatory in England.

“Informed and educated choices about health interventions are more beneficial in the long-term than enforcing them.

“This policy was brought forward despite concerns raised by professional bodies from across the health professions.

THORRUN GOVIND Thorrun Govind, chair of RPS in England

Little comfort

“This is a divisive issue and has put some staff in a really difficult position, often personally as well as professionally.

“This reversal may come as little comfort for those already affected by this policy, including those working in the care sector, and the Government and NHS must ensure they get the support they need.”

The mandatory vaccination policy for frontline healthcare workers, introduced in November, would have required the NHS employees and social care workers to be fully vaccinated by April 1.

The policy announced met resistance from some workers.

The government said on Monday (January 31) it planned to revoke mandatory Covid-19 vaccinations for health workers in England after warnings that an already-stretched service could face crippling staff shortages.

Health minister Sajid Javid said the government would launch a consultation into whether the policy announced in November was still needed.

"While vaccination remains our very best line of defence against Covid-19 I believe that it is no longer proportionate to require vaccination as a condition of deployment through statute," Javid told parliament.

More For You

RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less